# The Prognostic Value of PET/CT for Tumor Progression in Patients With Metastatic Hormone-sensitive Prostate Cancer

> **NCT06915714** · — · COMPLETED · sponsor: **Sun Yat-sen University** · enrollment: 45 (actual)

## Conditions studied

- Prostate Cancer Metastatic Disease
- PET / CT

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06915714
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-02
- **Primary completion:** 2025-02-20
- **Final completion:** 2025-02-28
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2025-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06915714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06915714, "The Prognostic Value of PET/CT for Tumor Progression in Patients With Metastatic Hormone-sensitive Prostate Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06915714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*